Market by Product and Service, Type, Application, Technology, Industry Verticals, and Country | Forecast 2021-2028
Triton Market Research’s report on the Asia-Pacific multiplex assay market predicts the market to showcase growth at a CAGR of 9.64% during the projected years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries assessed in this market include:
• India
• China
• Japan
• Australia & New Zealand
• South Korea
• ASEAN countries
• Rest of Asia-Pacific
In China, biopharmaceuticals are expanding beyond generics to produce personalized medicine, novel therapies, biomarkers, and multiplex assay. Additionally, several trends are surfacing across the country for multiplex assay. Besides, the country requires patient samples to be used in clinical trials to gain approval. Furthermore, the International Agency for Research on Cancer predicts the number of cancer cases to surge by 2030. This rise in cases is mainly owing to the rise in the aging population and unhealthy dietary habits. Along with this, the COVID-19 outbreak has increased the demand for newer and more effective technologies. Hence, these factors are likely to drive the growth of the multiplex assay market across China.
Furthermore, in Japan, the multiplex assay market is driven by government investment to promote drug development activities and strategic alliances among key market players. Additionally, the rising prevalence of cancer and better R&D infrastructure is adding to the studied market’s progression. It is estimated that the number of cancer cases is likely to surge by 2030. As a result, there is a gradual rise in the number of people undergoing screenings. Therefore, as mentioned above, all these factors are predicted to fuel the growth of the multiplex assay market within Japan.
Abcam is a developer and supplier of protein research tools. It majorly provides primary and secondary antibodies, inhibitors, imaging tools, reagents, and others. Moreover, the company serves academic researchers in detecting proteins for life sciences. Founded in 1998, Abcam operates through its manufacturing facilities across various countries, including Tokyo, Japan, Hong Kong, China, and Shanghai, among others.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON MULTIPLEX ASSAY MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. KEY
BUYING OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
AND PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8. KEY
DRIVERS
2.8.1. ADOPTION
OF PERSONALIZED MEDICINES
2.8.2. HIGH
ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.9. KEY
RESTRAINTS
2.9.1. DEARTH
OF SKILLED PROFESSIONALS
2.9.2. LEGAL
TRENDS RELATED TO ENVIRONMENTAL SAFETY
2.10. KEY
OPPORTUNITIES
2.10.1. FUNDING
FOR R&D ACTIVITIES BY VARIOUS GOVERNMENT AGENCIES AND COMPANIES
2.10.2. EMERGING
ECONOMIES OFFERING LUCRATIVE GROWTH OPPORTUNITIES
3. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS
AND CONSUMABLES
3.2. INSTRUMENTS
AND ACCESSORIES
3.3. SOFTWARE
AND SERVICES
4. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED
MULTIPLEX ASSAY
4.2. NUCLEIC
ACID-BASED MULTIPLEX ASSAY
4.3. OTHER
MULTIPLEX ASSAYS
5. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH
AND DEVELOPMENT
5.2. CLINICAL
DIAGNOSTICS
5.3. COMPANION
DIAGNOSTICS
6. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX
PROTEIN MICROARRAY
6.2. MULTIPLEX
PCR
6.3. OTHER
TECHNOLOGIES
7. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICALS
7.1. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
7.2. RESEARCH
INSTITUTES
7.3. CLINICAL
LABORATORIES
7.4. HOSPITALS
8. ASIA-PACIFIC
MULTIPLEX ASSAY MARKET – COUNTRY OUTLOOK
8.1. COUNTRY
ANALYSIS
8.1.1. CHINA
8.1.2. JAPAN
8.1.3. INDIA
8.1.4. AUSTRALIA
& NEW ZEALAND
8.1.5. SOUTH
KOREA
8.1.6. ASEAN
COUNTRIES
8.1.7. REST
OF ASIA-PACIFIC
9. COMPETITIVE
LANDSCAPE
9.1. ABCAM
9.2. AGILENT
TECHNOLOGIES INC
9.3. BECTON
DICKINSON AND COMPANY
9.4. BIO
RAD LABORATORIES INC
9.5. BIO
TECHNE CORPORATION
9.6. F
HOFFMANN LA ROCHE
9.7. ILLUMINA
INC
9.8. LUMINEX
CORPORATION
9.9. MERCK
MILLIPORE
9.10. MESO
SCALE DIAGNOSTICS LLC
9.11. OLINK
PROTEOMICS AB
9.12. QIAGEN
NV
9.13. RANDOX
LABORATORIES LTD
9.14. SEEGENE
INC
9.15. SIEMENS
HEALTHINEERS AG
9.16. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: ASIA-PACIFIC
MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: ASIA-PACIFIC
MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC
MULTIPLEX ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC
MULTIPLEX ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: ASIA-PACIFIC MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 2: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
PRODUCT AND SERVICE, 2020 & 2028 (IN %)
FIGURE 3: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 4: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
TYPE, 2020 & 2028 (IN %)
FIGURE 7: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
APPLICATION, 2020 & 2028 (IN %)
FIGURE 11: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 12: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 13: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 15: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
MULTIPLEX PCR, 2021-2028 (IN $ MILLION)
FIGURE 17: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 18: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY OTHER
TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 22: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY
HOSPITALS, 2021-2028 (IN $ MILLION)
FIGURE 24: CHINA MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 25: JAPAN MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 26: INDIA MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 27: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: SOUTH KOREA MULTIPLEX ASSAY MARKET 2021-2028
(IN $ MILLION)
FIGURE 29: ASEAN COUNTRIES MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 30: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)